Cell Culture Market is Expected to Raise at CAGR of 12.07% from 2023-2030

The global cell culture market was worth USD 22.22 billion in 2022 and is estimated to grow to USD 55.30 billion by 2030, with a compound annual growth rate (CAGR) of approximately 12.07% over the forecast period.

Continue ReadingCell Culture Market is Expected to Raise at CAGR of 12.07% from 2023-2030

Healthcare Distribution Market to be More Than $1.5 trillion by 2030

Global healthcare distribution market sales are expected to be worth $950 billion by 2023. This revenue will further grow at a CAGR of 7.0% from 2023 to reach $1,525.5 billion in 2030.

Continue ReadingHealthcare Distribution Market to be More Than $1.5 trillion by 2030

Allergy Treatment Market Analysis and Forecast to 2030: Free Smart Book

Key industry experts predict that the remote patient monitoring market will generate $25.1 billion in revenue by 2030, with a high CAGR of 6.5% between 2023 and 2030. The market for remote patient monitoring had been estimated around $10.8 billion in 2022.

Continue ReadingAllergy Treatment Market Analysis and Forecast to 2030: Free Smart Book
Read more about the article Global Cancer Immunotherapy Market Sales to Cross $200 Billion by 2030
Global Cancer Immunotherapy Market Sales to Cross $200 Billion by 2030

Global Cancer Immunotherapy Market Sales to Cross $200 Billion by 2030

Cancer immunotherapy market is expected to grow at the CAGR between 9-10% from 2022 to 2030 as this therapy is being rapidly adopted in the cancer treatment space. The major market drivers such as higher efficiency of cancer immunotherapy than traditional cancer treatments, rise in global cancer burden, initiatives by government cancer care funding, and easy reimbursement for cancer immunotherapy increase the overall acceptance of this therapy and boost the growth of the market. Owing to these factors global cancer immunotherapy market is expected to cross the $200 billion market size by 2030.

Continue ReadingGlobal Cancer Immunotherapy Market Sales to Cross $200 Billion by 2030